AIDS Clinical Trials Group (ACTG) A5164 was a randomized trial of early versus deferred ART in subjects with an acute AIDS-defining OI or a serious bacterial infection (defined as bacterial pneumonia or other bacterial infection of a deep tissue, body cavity, or other normally sterile site and a CD4+ T-cell count<200 cells/µL).
CA9-infected patients sometimes experienced fever and symptoms of upper respiratory tract infection, defined as rhinorrhea, cough, and/or sore throat (Table 1).
In comparison, force of infection, defined as the proportion of susceptible individuals that have become infected with Mycobacterium tuberculosis in a specified period, can be calculated using changes in age-specific prevalence rates[ 10- 12], and provides an estimate of recent infection incidence across a wider age range.
The force of infection, defined as the rate at which susceptible individuals acquire HIV, is the infectivity times the number of infected individuals.
The clinical significance of occult hepatitis B virus (HBV) infection, defined as the presence of HBV DNA in individuals with HBV core antibodies (anti-HBc) in the absence of HBV surface antigen (HBsAg), is unclear in HIV-infected patients.
We collected patient's clinical and biological parameters, especially ammonia levels, all the ongoing treatments, and seeked for the presence of evolutive infection defined as an infection considered as clinically relevant.
We first examined whether prevalent HPV infection (defined as HPV detection at baseline) was predictive of HIV acquisition.
To calculate the 'pristine' rate of decay in the seropositive population, infants who experienced at least 1 infection, defined as either an ELISA-confirmed or IFAT-confirmed serological increase, were excluded.
GROG doctors swabbed patients presenting with acute respiratory infection, defined as: sudden onset of a respiratory sign (cough, rhinitis, coryza,.) and a systemic sign evoking an infection (fever, asthenia, headache, myalgia, faintness).
We evaluated the performance of QF-TB-IT as a marker of TB infection, defined as LTBI children with a known family TB contact (32 children) and active TB children (32 children) versus healthy contacts (12 children) or children with LTBI and no TB contact (22 children).
For simulating this current scenario, we considered that, among prisoners entering the prison, the prevalence of latent TB infection (defined as a positive tuberculin skin test after excluding active TB cases) is 47.0% and that the prevalence of active TB (evaluated through X-ray screening and bacteriological diagnostic tests) is 1.5% (unpublished data).
